Microtubule-associated protein tau is abnormally hyperphosphorylated and aggregated into neurofibrillary tangles (NFTs) in the brain of individuals with Alzheimer's disease (AD) and related neurodegenerative diseases [1] [2] [3] . It is believed that hyperphosphorylation is responsible for loss of function, gain of toxicity, and aggregation of tau into paired helical filaments/NFTs [4] [5] [6] . The density of NFTs correlates with the dementia positively [7] [8] [9] . Thus, hyperphosphorylation of tau may play a key role in the etiopathogenesis of AD.
Glycogen synthase kinase 3b (GSK-3b) is one of the proline-directed protein kinases and plays an important role in tau hyperphosphorylation. It catalyzes tau phosphorylation at multiple sites in vitro and in vivo [10, 11] . Overexpression of GSK-3b in transgenic mice induces AD-like tau pathology-hyperphosphorylation and aggregation of tau [12] [13] [14] . Inhibition of GSK-3b prevents tau hyperphosphorylation in animal models [15] [16] [17] . In AD brain, GSK-3b is truncated by activated calpain [18, 19] . Truncated GSK-3b in AD brain is immunorecogonized by its N-terminal antibodies, suggesting C-terminal truncation of GSK-3b in AD brain [19] . Calpain proteolyzes GSK-3b and increases its kinase activity in vitro [19] [20] [21] . Calpain cleaves GSK-3b in vitro at C-terminal Ser 381 [19] or at Ile 384 [21] .
GSK-3b is constitutively active in the brain. The activity of GSK-3b is regulated by phosphorylation at Ser9 and Tyr216 [22, 23] . Protein kinase B/AKT, activated by PI3K signaling, phosphorylates GSK-3b at Ser9 and suppresses its activity [24, 25] . We previously reported that protein phosphatase 2A (PP2A) Abbreviations AD, Alzheimer's disease; GSK-3b, glycogen synthase kinase-3b; HRP, horseradish peroxidase; NFTs, neurofibrillary tangles; OA, okadaic acid; PP2A, protein phosphatase 2A.
efficiently dephosphorylates GSK-3b at Ser9 [26, 27] . Phosphorylation of Ser9 inhibits the cleavage of GSK3b by calpain at both N-and C termini [21] . However, the role of the C-terminal truncation in Ser9 phosphorylation is unclear. In the present study, we found that in AD brain, the level of Ser9 phosphorylation in truncated GSK-3b was lower than that in the full-length GSK-3b. Truncation promoted GSK-3b nuclear translocation. Truncated GSK-3b interacted with and was dephosphorylated by PP2Ac more strongly than the full-length enzyme.
Materials and methods

Human brain tissues
Medial frontal cortical tissue samples from seven AD and seven age-matched normal human brains used in this study (Table 1) were obtained from the Sun Health Research Institute Donation Program (Sun City, AZ, USA). All brain samples were from histopathologically confirmed cases and were stored at À70°C until used. The use of frozen human brain tissue was in accordance with the National Institutes of Health guidelines and was approved by our institute's institutional review committee.
Plasmids, proteins, and antibodies
pcDNA/GSK-3b was a kind gift from J. Avila (Centro de Biolog ıa Molecular, Universidad Aut onoma de Madrid, Madrid, Spain), from which pCI/HA-GSK-3b and pCI/HA-GSK-3b , truncated GSK-3b (GSK3b Trun ), were constructed and confirmed by sequencing. PP2A holoenzyme was purchased from Upstate Biotechnology Inc. (Lake Placid, NY, USA). Primary antibodies R127 against a.a. 364-377 of GSK-3b and R133 against a.a. 1-13 of GSK-3a/b were generated in our laboratory [19, 28] . Anti-GSK-3b (27C10) and anti-pSer9-GSK-3b were obtained from Cell Signaling Technology (Danvers, MA, USA). Monoclonal anti-a-tubulin (DM1A) was from ThermoFisher Scientific (Rockford, IL, USA). Monoclonal anti-HA and monoclonal anti-NeuN were from Sigma (St. Louis, MO, USA). Monoclonal anti-PP2A catalytic subunit was from BD Bioscience (Franklin Lakes, NJ, USA). All antibodies used in this study were characterized and did not show nonspecific reaction. Horseradish peroxidase (HRP) conjugated anti-mouse and anti-rabbit IgG were obtained from Jackson ImmunoResearch Laboratories (West Grove, PA, USA). Enhanced chemiluminescence (ECL) kit was from ThermoFisher Scientific.
Cell culture and transfection
HEK-239A and HeLa cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% FBS and N2a cells were supplemented with 10% horse serum and 5% FBS at 37°C in 5% CO 2 atmosphere. All transfections were performed with Lipofectamine 3000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. Tangle score was a density estimate and was designated as none, sparse, moderate or frequent (0, 1, 2, or 3 for statistics), as defined according to CERAD Alzheimer disease criteria [45] . Five areas (frontal, temporal, parietal, hippocampal, and entorhinal) were examined, and the scores were combined for a maximum of 15.
Western blots analyses
Human brain tissue was homogenized in 9 volumes of cold buffer containing 50 mM Tris-HCl, pH 7.4, 8.5% sucrose, 10 mM b-mercaptoethanol, and 2.0 mM EDTA. After adding twofold concentrated Laemmli buffer, the brain homogenates were boiled for 5 min and the protein concentration was measured by using modified Lowry. The same amount of protein from each sample was analyzed by sodium dodecyl sulfate/polyacrylamide gel electrophoresis and electro-blotted onto PVDF membrane. After blocking with 5% fat-free milk, the membrane was incubated with primary antibodies, such as GSK-3b antibody R127 (1 : 3000) and R133 (1 : 3000), 27C10 (1 : 1000), anti-HA (1 : 30 000) or anti-pSer9-GSK3b (1 : 1000), overnight in the presence of 0.1% NaN 3 in 5% fat-free milk at room temperature. After washing with TBST (Tris-HCl, pH 7.4, 150 mM NaCl, 0.05% Tween 20) three times, the membrane was incubated with the corresponding HRP-conjugated secondary antibody for~2 h. After washing with TBST, the blot was visualized by enhanced chemiluminescence and quantified by densitometry using MULTI GAUGE V2.3 software (Fuji Film, Tokyo, Japan).
Immunofluorescence staining
HeLa or N2a cells were plated on glass coverslips in 24-well plates and transfected with pCI/HA-GSK-3b FL and pCI/HA-GSK-3b Trun . Two days later, the cells were washed with PBS and fixed with 4% paraformaldehyde in PBS for 30 min at room temperature. After washing with PBS, the cells were blocked with 10% goat serum in 0.2% Triton X-100-PBS for 1 h at 37°C, and incubated with rabbit anti-GSK-3b ( 
Subcellular fractionation
Frontal cortices from three AD cases were homogenized in buffer containing 50 mM Tris-HCl, pH 7.4, 8.5% sucrose, 10 mM b-mercaptoethanol, 50 mM NaF, and 2.0 mM EDTA, 10 lgÁmL À1 of leupeptin, aprotinin, and peptstin.
The brain homogenates were centrifuged at 900 g for 5 min, the pellets were homogenized and centrifuged. The two supernatants were pooled together as cytoplasm fraction and the pellet was nuclear fraction.
Dephosphorylation of GSK-3b in cell lysate
Full-length GSK-3b (GSK-3b FL ) and truncated GSK-3b (GSK-3b Trun ) tagged with HA were overexpressed in HEK-293A cells. The cells were lysed by sonication in the cold buffer 50 mM Tris-HCl, pH7.4, 1 mM MnCl 2 , 10 mM bmercaptoethanol, 0.1% NP-40, 0.1% Triton X-100, 0.2% Sodium deoxycholate, 1 mM PMSF, 10 lgÁmL À1 of each aprotinin, leupeptin, and pepstatin. The cell lysates were incubated for various time in the presence or absence of okadaic acid (OA) at 30°C and subjected to western blots for measurement of GSK-3b phosphorylation.
Affinity-purification of HA-tagged GSK-3b
HEK-293A cells transfected with pCI/HA-GSK-3b FL or pCI/HA-GSK-3b Trun were washed twice with PBS, and lysed with buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 50 mM NaF, 1 mM Na 3 VO 4 , 0.1% NP-40, 0.1% Triton X-100, 0.2% sodium deoxycholate, 2 mM EDTA, 10 mM bmercaptoethanol, 5 mM AEBSF, 10 lgÁmL À1 aprotinin, 10 lgÁmL À1 leupeptin, and 10 lgÁmL À1 pepstatin) on ice.
Insoluble materials were removed by centrifugation at 16 000 g for 10 min. The supernatant was incubated with monoclonal anti-HA antibody precoupled onto protein G beads (Thermo fisher Scientific) overnight at 4°C. The beads were washed twice with lysis buffer and twice with TBS. The affinity purified HA-GSK-3b was confirmed by western blots and subjected to dephosphorylation assay by PP2A in vitro.
Coimmunoprecipitation GSK-3b FL and GSK-3b Trun were overexpressed in HEK-293A cells for 48 h as described above. The cells were washed twice with PBS and lysed by sonication in cold buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 50 mM NaF, 1 mM Na 3 VO 4 , 2 mM EDTA, 1 mM PMSF, and protease inhibitor cocktail). Insoluble materials were removed by centrifugation at 16 000 g for 10 min. The supernatants were incubated with anti-HA-coupled protein G-agarose beads (ThermoFisher Scientific) overnight at 4°C. The beads were washed twice with lysis buffer and twice with TBS. The bound proteins were eluted from the beads by boiling in Laemmli sample buffer and subjected to western blot developed with the indicated primary antibodies.
Dephosphorylation of GSK-3b by PP2A
Immunopurified GSK-3b FL and GSK-3b Trun with anti-HA as described above were incubated with various amounts of PP2A holoenzyme at 30°C for 10 min in reaction buffer (50 mM Tris-HCl, pH 7.4, 10 mM b-mercaptoethanol, 1.0 mM MnCl 2 ). The reaction was stopped by adding equal volume of 2X Laemmli buffer and boiling for 5 min. The phosphorylation level of GSK-3b was analyzed by western blots developed with anti-pSer9-GSK-3b.
Statistical analysis
Data were presented as mean AE SD and analyzed by the unpaired or paired two-tailed Student's t-test or MannWhitney test (for the data with non-normal distribution) for two groups comparison.
Results
Ser9 phosphorylation level of truncated GSK-3b is lower than its full-length enzyme in AD brain
Phosphorylation of GSK-3b at Ser9 suppresses its kinase activity. In the previous study, we found that GSK-3b is truncated at its C terminus in AD brain (Fig. 1A) , which is caused by activated calpain I [19] .
To determine whether the level of phosphorylation of the full-length GSK-3b (GSK-3b FL ) is different from that of the truncated GSK-3b (GSK-3b Trun ) in AD brain, we analyzed phosphorylation levels of GSK3b FL and GSK-3b Trun in the homogenates of frontal cortices from seven control and seven AD cases by western blots. We found that GSK-3b was truncated much more in AD brain than control brain (Fig. 1A) .
The phosphorylation level of GSK-3b at Ser9 was reduced in AD brain (Fig. 1A,B) . The phosphorylation of GSK-3b Trun was reduced more than GSK-3b FL , (Fig. 1A,C) . These data suggest that truncation of GSK-3b may impact its Ser9 phosphorylation.
Truncation of GSK-3b suppresses its phosphorylation at Ser9 in cultured cells
Our previous study showed that calpain I proteolyzed GSK-3b at its C-terminal Ser 381 in vitro and GSK-3 b 1-381 had higher activity than GSK-3b FL in phosphorylating tau [19] . The kinase activity of GSK-3b is well known to be inhibited by its phosphorylation at Ser9.
To study the effect of truncation on GSK-3b phosphorylation, we overexpressed HA-tagged GSK-3b (GSK-3b Trun ) and GSK-3b FL in HEK-293A cells and The phosphorylation levels of full length and truncated GSK3b in AD brains were normalized with the corresponding forms of GSK-3b determined by R127, respectively, and statistically analyzed with paired student t-test to compare the phosphorylation levels between full-length GSK-3b and truncated GSK-3b. The data are presented as mean AE SD; ***P < 0.001; ****P < 0.0001.
measured their phosphorylation at Ser9 by western blots. We found that the level of Ser9 phosphorylation of GSK-3b Trun was less than that of the GSK-3b FL ( Fig. 2A,B) , suggesting that the C-terminal truncation of GSK-3b suppresses its Ser9 phosphorylation.
To determine whether the truncation of GSK-3b affects its subcellular localization, we overexpressed GSK-3b FL and GSK-3b Trun in HeLa cells and immunostained with anti-GSK-3b. We found that GSK-3b FL was mainly located in the cytoplasm while GSK-3b Trun was distributed in both the cytoplasm and the nucleus (Fig. 2C) . The ratio of GSK-3b Trun fluorescence intensity in the nucleus and the cytoplasm was higher than that of GSK-3b FL (Fig. 2D) . To confirm the effect of C-terminal truncation on its subcellular localization, we overexpressed them in N2a cells and analyzed their localization. We found that both GSK-3b FL and GSK-3b Trun were mainly localized in the cytoplasm, but nuclear localization of GSK-3b Trun was more than that of GSK-3b FL (Fig. 2E ). There was a slight increase in the ratio of nucleus/cytoplasm of GSK-3b Trun fluorescence as compared with GSK-3b FL (Fig. 2F) . These data suggest that C-terminal truncation of GSK-3b may promote its nuclear localization.
To determine the subcellular localization of truncated GSK-3b in AD brain, we separated cytoplasm and nucleus by subcellular fractionation and then measured the expression of GSK-3b by western blots. We found that NeuN, a nuclear marker of neuron, was expressed in the nuclear fractions and a-tubulin was mainly expressed in the cytoplasm fraction (Fig. 2G) . In the cytoplasm fraction, GSK-3b FL was more than GSK-3b Τrun , while in the nucleus GSK-3b FL was lower than GSK-3b Trun , resulting in a higher ratio of GSK3b FL /GSK-3b Trun in the cytoplasm than that in the nucleus (Fig. 2H) . Thus, this result suggests that in AD brain truncation of GSK-3b promotes its nuclear translocation.
Truncated GSK-3b is dephosphorylated more effectively
The protein is phosphorylated by kinase with ATP and dephosphorylated by phosphatase. Lysis of cells impairs the machinery of ATP synthesis. Thus, incubation of the cell lysate causes the dephosphorylation of the cellular proteins by the phosphatases. To learn the effect of the truncation on Ser9 dephosporylation of GSK-3b, we overexpressed GSK-3b FL and GSK3b Trun in HEK-293A cells and lysed the cells 48 hrs after transfection. The cell lysates were incubated for various time points at 30°C. Ser9 phosphorylation of GSK-3b was analyzed by western blots. We found that incubation significantly caused Ser9 dephosphorylation of GSK-3b in a time-dependent manner (Fig. 3A,B) . However, the Ser9 dephosphorylation of GSK-3b Trun was greater than that of GSK-3b FL (Fig. 3A,B) , suggesting that truncation of GSK-3b enhances its dephosphorylation by phosphatases in cell lysate.
To confirm the role of phosphatase(s) in GSK-3b dephosphorylation at Ser9, we incubated the cell lysate with GSK-3b FL overexpression for 15 min at 30°C in the presence of various concentrations of OA to inhibit phosphatases (mainly PP2A) activity and then, analyzed the phosphorylation level of GSK-3b at Ser9 by western blots. We found that the dephosphorylation of exogenous and endogenous GSK-3b FL at Ser9 was inhibited by OA in a dose-dependent manner (Fig. 3C,D) . A total of 10 nM OA almost completely suppressed Ser9 dephosphorylation of GSK-3b (Fig. 3C,D) .
To compare the role of OA in the dephosphorylation of both GSK-3b FL and GSK-3b Trun by incubation, we incubated the cell lysates of GSK-3b FL and GSK-3b Trun for various periods at 30°C in the presence of 20 nM OA and analyzed Ser9 phosphorylation by western blots. We found that 20 nM OA completely blocked Ser9 dephosphorylation of either GSK-3b FL or GSK-3b Trun (Fig. 3E,F) , suggesting that phosphatases contribute to the reduction in Ser9 phosphorylation of GSK-3b in cell lysate during the incubation.
PP2A interacts with and dephosphorylates GSK-3b Trun more effectively
Okadaic acid inhibits PP2A predominantly. PP2A is the major phosphatase to dephosphorylate GSK-3b in vitro and in vivo [26, 27] . To learn whether truncation affects the interaction of GSK-3b with PP2A, we overexpressed GSK-3b FL and GSK-3b Trun in HEK-293A cells, immunoprecipitated them with anti-HA, and then analyzed PP2A catalytic subunit, PP2Ac, by western blots. We found that similar amount of PP2Ac was coimmunoprecipitated by much more GSK-3b FL than GSK-3b Trun (Fig. 4A) , suggesting PP2Ac interacts with GSK-3b Trun stronger than with GSK-3b FL .
GSK-3b FL was mainly located in the cytoplasm, while GSK-3b Trun was found in the cytoplasm and the nucleus ( Figs 2C-F and 4B,C) . Interestingly, PP2Ac also located both in the nucleus and in the cytoplasm (Fig. 4B,C ) and well colocalized with GSK-3b Trun , indicating that GSK-3b Trun interacts with PP2Ac (Fig. 4B) . The distribution of PP2Ac in the nucleus and the cytoplasm of HeLa cells overexpressed with GSK-3b Trun or GSK-3b FL was similar (Fig. 4C) .
To determine the effect of the truncation on GSK3b dephosphorylation by PP2A, we overexpressed HAtagged GSK-3b FL or GSK-3b Trun in HEK-293A cells and immunopurified them with anti-HA. We then incubated these immunopurifed GSK-3bs with various concentrations of PP2A holoenzyme at 37°C for 10 min and measured Ser9 phosphorylation of GSK3b by western blots. We found that phosphorylation level of GSK-3b Trun was decreased at higher rate than that of GSK-3b FL (Fig. 4C,D) , suggesting that the dephosphorylation of GSK-3b Trun by PP2A is more efficient than that of GSK-3b FL .
Discussion
GSK-3b is one of the major tau kinases [11, 28] . Its activity is suppressed by its phosphorylation at Ser9 [22] . In AD brain, GSK-3b is truncated at the Fig. 2 . Truncated GSK-3b is located in both the cytoplasm and the nucleus and less phosphorylated in cultured cells. (A, B) GSK-3b FL and GSK-3b Trun (GSK-3b 1-381 ) were expressed in HEK-293A cells. The cells were lysed with Laemmli buffer and analyzed by western blots with GSK-3b antibody (27C10) (A). The phosphorylation levels of GSK-3b FL and GSK-3b Trun were quantified by densitometry and normalized with the corresponding forms of GSK-3b. (B). FL, full length; Endo, endogenous; Trun, truncated. (C-F) GSK-3b FL and GSK-3b Trun were overexpressed in HeLa cells (C) and N2a cells (E) and immunostained with antibody against GSK-3b (27C10) followed by florescence labeled anti-rabbit IgG (red). The fluorescence level of GSK-3b in the nucleus and the cytoplasm was measured by IMAGEJ. The ratio of GSK-3b fluorescence level in the nucleus and in the cytoplasm was calculated (D, F). Hoechst stained nuclei. (G, H) Frontal cortices from three AD cases were homogenated. Cytoplasm and nucleus were separated by centrifugation at 900 g for 5 min and subjected to the western blots developed with anti-GSK-3b (R127), anti-NeuN, and a-tubulin (DM1A). The ratio of GSK-3b FL /GSK-3b Trun was calculated and analyzed by paired t-test. The data are presented as mean AE SD, *P < 0.05; ***P < 0.001. C-terminal [19] . In the present study, we found that Ser9 phosphorylation of truncated GSK-3b was less than its full-length enzyme in AD brain and in cultured cells. Truncation of GSK-3b promoted its nuclear translocation and enhanced its interaction with PP2A, leading to its Ser9 dephosphorylation by PP2A. In combination with previous findings that GSK-3b is truncated by overactivated calpain I in AD brain and that the proteolysis of recombinant GSK-3b by calpain I at its C terminus enhances its kinase activity, we propose here that truncation of GSK-3b by calpain I in AD enhances its kinases activity directly and also indirectly through its Ser9 dephosphorylation by PP2A, contributing to hyperphosphorylation of tau.
GSK-3b phosphorylates tau at multiple sites in vitro and in vivo [10, 11] . Prephosphorylation of tau by other kinases, such as PKA, cdk5, Dyrk1A, and CK1, makes tau to be a favorable substrate for GSK-3b [29] [30] [31] . In addition to phosphorylating tau, GSK-3b also phosphorylates SC35 [32] , a splicing factor that plays a critical role in the tau exon 10 inclusion [33] , and suppresses tau exon 10 inclusion [32] . Tau exon 10 encodes the second microtubule-binding repeat. Its alternative splicing generates tau isoforms with three or four microtubule-binding repeats, named 3R-tau and 4R-tau. In normal human brain, 3R-tau and 4R-tau are expressed in 1 : 1 ratio [34, 35] . However, several silence mutations of tau causing frontotemporal dementia with Parkinsonism linked to chromosome 17 only affect tau exon 10 splicing, but do not affect its primary structure, suggesting that dysregulation of tau exon 10 splicing is enough to cause neurodegeneration [36] [37] [38] . Here, we found that truncation of GSK-3b promotes its nuclear translocation, where splicing machinery locates in. Moreover, the nuclear translocation of GSK-3b may lead to less efficiency to phosphorylate tau. However, increased GSK-3b activity resulting from its truncation directly or indirectly through Ser9 dephosphorylation may contribute to tau pathogenesis in AD brain. Specific block the truncation of GSK-3b by molecular biological or/and pharmacological strategies will help us to understand the role of calpain-GSK-3b in AD pathogenesis or progression. GSK-3b is dephosphorylated at Ser9 by PP2A [26, 27, 39] . PP2A is the major phosphatase that accounts for > 70% tau phosphatase activity in human brain [40] . In the present study, we found that truncated GSK-3b was coimmunoprecipitated and colocalized with PP2Ac more strongly than its full-length enzyme. PP2A dephosphorylated truncated GSK-3b more effectively than full-length GSK-3b. The C terminus of GSK-3b may interfere the interaction of GSK3b and PP2A. GSK-3b is almost exclusively present in the cytoplasm, but deletion of the C-terminus promoted its nuclear translocation. However, much more abundant nuclear localization of GSK-3b Trun was observed in HeLa cells than in N2a cells, which may result from different post-translational modifications. It is reported that GSK-3b interacts with 14-3-3f through its N terminus [41] . It is reported that 14-3-3f enhances nuclear localization of TERT by inhibiting the CRM1 binding to the TERT NES-like motif [42] . However, whether truncation of GSK-3b affects its interaction with 14-3-3, consequently affects its subcellular location remains to be determined.
GSK-3b is truncated dramatically in AD brain and the truncated form is reacted with the antibodies Fig. 4 . Truncated GSK-3b is interacted with and dephosphorylated by PP2A more effectively. (A) GSK-3b FL and GSK-3b Trun tagged with HA were expressed in HEK-293A cells and immunoprecipitated by anti-HA. The immunoprecipitated proteins were analyzed by western blots with anti-PP2Ac and anti-GSK-3b (27C10). FL, full length; Endo, endogenous; Trun, truncated. (B, C) GSK-3b FL and GSK-3b Trun were overexpressed in HeLa cells and inmmuno-stained by polyclonal anti-GSK-3b and monoclonal anti-PP2Ac followed by florescence labeled anti-rabbit (red) and anti-mouse (green) second antibodies. The fluorescence levels of the nucleus and the cytoplasm were measured by IMAGEJ. Nucleus/cytoplasm ratio of GSK-3b or PP2Ac was calculated and analyzed statistically by unpaired two-tailed Student's t-test. The data are presented as mean AE SD, *P < 0.05. Hoechst stained nuclei. (C, D) GSK-3b FL and GSK-3b Trun tagged with HA were overexpressed in HEK-293A cells and immunopurified by anti-HA. The GSK-3bs were incubated with various amounts of PP2A holoenzyme for 10 min at 30°C and analyzed by western blots with anti-pS9-GSK-3b and anti-GSK-3b. The phosphorylation levels of GSK-3bs were normalized with GSK-3b and plotted against arbitrary units of PP2A.
against N-terminal, but not C-terminal GSK-3b, suggesting that the truncation may appear at the C terminus [19] . Calpains in vitro cleave GSK-3b at N-and/or C termini [19] [20] [21] and enhance its kinase activity. Thus, both N-and C termini of GSK-3b may interact with its kinase domain and serve as inhibitory domain. However, the molecular mechanism remains elusive.
Calpain I and calpain II are the most studied and abundant calpain molecules in the brain [43] . They proteolyze the same substrates but require micromolar and millimolar calcium, respectively. Calpain II cleaves recombinant GSK-3b in vitro at N-and/or C termini [20, 21] . Ser9 phosphorylation inhibits either N-or Cterminal truncations of GSK-3b [21] . By using immunopurifed GSK-3b from HEK-293FT cells, we found that calpain I cleaved GSK-3b at C-terminal Ser381 [19] . Thus, we speculate that calpain I and II may cleave different sites. Post-translational modification of GSK-3b may affect its proteolysis by calpain.
In conclusion, C-terminal truncation of GSK-3b promotes its nuclear translocation, enhances its interaction with and dephosphorylation by PP2A. In AD brain, C-terminal truncation of GSK-3b increases its kinase activity directly and indirectly through its dephosphorylation by PP2A, which may contribute to tau pathogenesis through hyperphosphorylation of tau and/or dysregulation of tau exon 10 splicing.
